---
title: "Fibrobiologics (FBLG.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/FBLG.US/norm.md"
symbol: "FBLG.US"
name: "Fibrobiologics"
parent: "https://longbridge.com/zh-CN/quote/FBLG.US.md"
datetime: "2026-05-20T23:01:21.092Z"
locales:
  - [en](https://longbridge.com/en/quote/FBLG.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/FBLG.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/FBLG.US/norm.md)
---

# Fibrobiologics (FBLG.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -1.33 | -1.08 | -2.68 | -2.41 | -2.71 |
| ROE | -456.83% | -413.18% | -4692.79% | -1160.87% | -781.28% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -5.00M | -3.24M | -5.78M | -4.66M | -4.97M |
| 营业利润 | -5.07M | -2.59M | -5.04M | -4.49M | -4.53M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 5.94M | 9.62M | 8.74M | 13.91M | 11.43M |
| 权益乘数 | 2.28 | 1.56 | 69.95 | 16.17 | 4.86 |
| 每股净资产 | 0.7401 | 1.85 | 0.0518 | 0.4209 | 1.25 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 1.48M | 4.89M | 4.87M | 8.85M | 8.67M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 2.98M | 3.22M | 3.46M | 3.68M | 2.10M |
| 净债务 | 996000.00 | -2.48M | 2.25M | 1.93M | -1.55M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -4.36M | -3.16M | -3.97M | -3.98M | -5.28M |
| 投资现金流 | - | 0.0000 | -6000.00 | -213000.00 | -43000.00 |
| 融资现金流 | 952000.00 | 3.19M | 0.0000 | 4.38M | - |
| 自由现金流 | -3.09M | -2.22M | -2.02M | -2.45M | -3.78M |
| 现金流充裕率 | -5387.65% | -93.03% | -66200.00% | -1870.42% | -12267.44% |
| 举债与偿债 | 327000.00 | 0.0000 | 0.0000 | 4.38M | - |
| 资本支出 | - | 0.0000 | -6000.00 | -213000.00 | -43000.00 |